GLENMEDE TRUST CO NA - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,967,751
+13.0%
38,953
+2.0%
0.02%
+15.0%
Q2 2023$3,511,9160.0%38,1730.0%0.02%0.0%
Q1 2023$3,511,916
+8.4%
38,173
+6.9%
0.02%
+5.3%
Q4 2022$3,240,789
+16.0%
35,723
-2.9%
0.02%
+5.6%
Q3 2022$2,794,000
-21.2%
36,771
-12.4%
0.02%
-14.3%
Q2 2022$3,547,000
-5.7%
41,975
-2.1%
0.02%
+16.7%
Q1 2022$3,762,000
-2.0%
42,889
-2.3%
0.02%0.0%
Q4 2021$3,840,000
+13.2%
43,915
+5.8%
0.02%0.0%
Q3 2021$3,393,000
-10.8%
41,510
-0.5%
0.02%
-10.0%
Q2 2021$3,805,000
+1.8%
41,720
-4.6%
0.02%0.0%
Q1 2021$3,736,000
-36.7%
43,722
-30.1%
0.02%
-37.5%
Q4 2020$5,906,000
+0.2%
62,559
-7.7%
0.03%
-8.6%
Q3 2020$5,892,000
-14.5%
67,769
-14.1%
0.04%
-16.7%
Q2 2020$6,888,000
-28.0%
78,884
-21.9%
0.04%
-4.5%
Q1 2020$9,566,0000.0%101,0350.0%0.04%0.0%
Q4 2019$9,566,000
+8.3%
101,035
-0.6%
0.04%
+10.0%
Q3 2019$8,831,000
-2.9%
101,642
+2.0%
0.04%0.0%
Q2 2019$9,096,000
-4.4%
99,635
+0.6%
0.04%
-7.0%
Q1 2019$9,517,000
+126.7%
99,010
+102.3%
0.04%
+115.0%
Q4 2018$4,198,000
-35.4%
48,933
-35.2%
0.02%
-23.1%
Q3 2018$6,501,000
+0.5%
75,459
-11.9%
0.03%
-10.3%
Q2 2018$6,470,000
-2.8%
85,651
+8.0%
0.03%
+3.6%
Q1 2018$6,658,0000.0%79,3130.0%0.03%0.0%
Q4 2017$6,658,000
-4.5%
79,313
-2.3%
0.03%
-9.7%
Q3 2017$6,969,000
+2.2%
81,196
-11.6%
0.03%
-6.1%
Q2 2017$6,821,0000.0%91,8630.0%0.03%0.0%
Q1 2017$6,821,000
-10.8%
91,863
-12.5%
0.03%
-21.4%
Q4 2016$7,646,000
-5.9%
104,992
+2.0%
0.04%
-8.7%
Q3 2016$8,123,000
-9.4%
102,887
-5.3%
0.05%
-14.8%
Q2 2016$8,967,000
+0.4%
108,700
-11.8%
0.05%
-6.9%
Q1 2016$8,930,000
-20.3%
123,290
-5.4%
0.06%
-24.7%
Q4 2015$11,208,000
-21.0%
130,289
-15.6%
0.08%
-26.0%
Q3 2015$14,188,000
+0.2%
154,365
+7.2%
0.10%
+2.0%
Q2 2015$14,157,000
-10.3%
143,973
-10.1%
0.10%
-11.3%
Q1 2015$15,789,000
-9.9%
160,129
-15.3%
0.12%
-16.1%
Q4 2014$17,518,000
+0.3%
189,081
+1.9%
0.14%
-10.5%
Q3 2014$17,468,000
-2.4%
185,592
-6.1%
0.15%
-5.0%
Q2 2014$17,889,000
+4.3%
197,611
-2.0%
0.16%
+1.3%
Q1 2014$17,151,000
-12.7%
201,743
-17.5%
0.16%
-20.9%
Q4 2013$19,655,000
+3.1%
244,541
-1.6%
0.20%
-11.1%
Q3 2013$19,057,000
+8.2%
248,441
-0.3%
0.23%
+3.2%
Q2 2013$17,618,000
+681.3%
249,175
+534.4%
0.22%
-43.1%
Q4 2007$2,255,0000.0%39,2750.0%0.38%0.0%
Q4 2006$2,255,00039,2750.38%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders